Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Piers Nicholas Plowman Insider Profile
4 Followers
Piers Nicholas Plowman, Director at Advanced Oncotherapy, holds 4.68M shares in Advanced Oncotherapy (Ticker: GB:AVO).
Piers Nicholas Plowman Advanced Oncotherapy (AVO)Director
Advanced Oncotherapy (AVO)
Director
Ranked #32,076 out of 98,909 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+44.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Piers Nicholas Plowman does not currently own shares as a corporate insider.
A breakdown of Piers Nicholas Plowman's holdings
Insider Roles
Piers Nicholas Plowman does not currently hold a role as a corporate insider.
Roles that Piers Nicholas Plowman holds in companies
Most Profitable Insider Trade
Stock:
Advanced Oncotherapy
(AVO)
(AVO)
Rating:Informative Buy
Date:May 08, 2017 - May 08, 2018
Return:+116.40%
The most profitable trade made by Piers Nicholas Plowman
Piers Nicholas Plowman's Trading History
List of latest transactions for each holding click on a transaction to see Piers Nicholas Plowman's performance on stock
You May Also Like
Piers Nicholas Plowman insider profile FAQ
What is the percentage of profitable transactions made by Piers Nicholas Plowman?
The percentage of profitable transactions made by Piers Nicholas Plowman is 50%.
What is the average return per transaction made by Piers Nicholas Plowman?
The average return per transaction made by Piers Nicholas Plowman is 44.30%.
What stocks does Piers Nicholas Plowman hold?
Piers Nicholas Plowman holds: GB:AVO stocks.
What was Piers Nicholas Plowman’s latest transaction?
Piers Nicholas Plowman latest transaction was an Uninformative Buy of 40.00K.
What was Piers Nicholas Plowman's most profitable transaction?
Piers Nicholas Plowman’s most profitable transaction was an Informative Buy of GB:AVO stock on May 8, 2017. The return on the trade was 116.40%.
What is Piers Nicholas Plowman's role in Advanced Oncotherapy?
Piers Nicholas Plowman's role in Advanced Oncotherapy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.